MedDataX Logo

Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release

NCT ID: NCT00492414

Last Updated: 2007-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Panic disorder(PD)is a disabling psychiatric condition associated with significant impairment in psychosocial, occupational functioning and quality of life, as mentioned by mogotsi et al. So, most patients with panic disorder suffers from the consequences of the impairment in occupational function. This impairment is not only individual problem, but also social one. Since productivity is very important item required to employees, lost productive time among workers with psychiatric illness should be reduced by the proper management. But few data were reported in this field by now.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Panic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paroxetine CR

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female outpatients aged 20-50 years
2. In female, is eligible to enter this study if she is if

* Non-childbearing potential(note:women who are 6 months post-menopausal are not considered women of child-bearing potential)
* child-bearing potential, has a negative urine dipstick pregnancy test, and is practicing a clinically acceptable method of contraception such as oral contraception, surgical sterilization, I.U.D.,systemic contraception, or double barrier contraception(any two of diaphragm/spermicidal foar/condom)
3. Subject currently meets the diagnosis for PD according to korean version of Anxiety Disorder Interview Schedule for DSM-IV(ADIS-IV) through a comprehensive psychiatric evaluation and not being treated currently.
4. Subject must have the ability to comprehend the key components of the consent form and provide informed consent.

Exclusion Criteria

1. Subject who has a history of any other major medical or psychiatric illnesses except PD or PD with major depressive disorder.
2. Subject who retired or left his job or who plan to retire within two years.
3. is a current homicidal or suicidal risk in the investigator's judgement.
4. is currently pregnant, lactating or planning to become pregnant within the next 3 months
5. is currently participating in any other clinical trial or taking any non-approved or experimental medication.
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

GlaxoSmithKline

INDUSTRY

Sponsor Role collaborator

Inje University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jong-Min Woo, Master

Role: PRINCIPAL_INVESTIGATOR

Seoul Paik Hospital, Inje University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul Paik Hospital, Inje University

Seoul, Seoul, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eun-Joo Jung

Role: CONTACT

[email protected]
+82-2-2270-0940

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eun-Joo Jung

Role: primary

[email protected]
+82-2-2270-0940

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COL110010

Identifier Type: -

Identifier Source: org_study_id